Progression and regression of coronary atherosclerosis.

[1]  W. Kannel,et al.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.

[2]  G. Mancini,et al.  Quantitative coronary angiography , 1994 .

[3]  J. Hupp.  Lowering Blood Cholesterol to Prevent Heart Disease , 1985, International Journal of Technology Assessment in Health Care.

[4]  D. Blankenhorn.  Two new diet-heart studies. , 1985, The New England journal of medicine.

[5]  B Buis,et al.  Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. , 1985, The New England journal of medicine.

[6]  J. J. Gerbrands,et al.  Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. , 1985, Circulation.

[7]  H. Jansen,et al.  Enzymology and physiological role of hepatic lipase. , 1985, Biochemical Society transactions.

[8]  Roger A. Renfrew,et al.  Lipid Research Clinics Program. , 1984, JAMA.

[9]  M. Frick,et al.  Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. , 1984, British medical journal.

[10]  W. Grossman,et al.  Angina pectoris. Natural history and strategies for evaluation and management. , 1984, The New England journal of medicine.

[11]  S. Kelsey,et al.  The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. , 1984, Circulation.

[12]  H. Schwertner,et al.  Relationship between Cortisol and Cholesterol in Men with Coronary Artery Disease and Type A Behavior , 1984, Arteriosclerosis.

[13]  B. Rifkind,et al.  Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia. , 1983, JAMA.

[14]  M. Frick,et al.  Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. , 1983, The American journal of cardiology.

[15]  B. Lewis,et al.  TREATMENT OF HYPERLIPIDAEMIA RETARDS PROGRESSION OF SYMPTOMATIC FEMORAL ATHEROSCLEROSIS A Randomised Controlled Trial , 1983, The Lancet.

[16]  G. Schonfeld.  Disorders of lipid transport--update 1983. , 1983, Progress in cardiovascular diseases.

[17]  C. Glueck.  Relationship of lipid disorders to coronary heart disease. , 1983, The American journal of medicine.

[18]  I. Holme,et al.  MRFIT and the Oslo study. , 1983, Journal of the American Medical Association (JAMA).

[19]  P. Canner,et al.  High‐density Lipoprotein Cholesterol and Prognosis After Myocardial Infarction , 1982, Circulation.

[20]  H. Buchwald,et al.  Overview of randomized clinical trials of lipid intervention for atherosclerotic cardiovascular disease. , 1982, Controlled clinical trials.

[21]  W. Kannel,et al.  THE SEARCH FOR AN OPTIMUM SERUM CHOLESTEROL , 1982, The Lancet.

[22]  F. Tristani,et al.  Factors Affecting the Extent and Severity of Coronary Artery Disease in Patients Enrolled in the Coronary Artery Surgery Study , 1982, Arteriosclerosis.

[23]  W. M. Smith,et al.  Multiple risk factor intervention trial (MRFIT). , 1981, Preventive medicine.

[24]  R. Levy.  Cholesterol, lipoproteins, apoproteins, and heart disease: present status and future prospects. , 1981, Clinical chemistry.

[25]  J. Willems,et al.  Coronary arterial lesions in young men who survived a first myocardial infarction: clinical and electrocardiographic predictors of multivessel disease. , 1981, The American journal of cardiology.

[26]  A. Selzer,et al.  Role of coronary arteriography in the evaluation of patients with coronary artery disease. , 1981, The American journal of medicine.

[27]  A. Bruschke,et al.  The Anatomic Evolution of Coronary Artery Disease Demonstrated by Coronary Arteriography in 256 Nonoperated Patients , 1981, Circulation.

[28]  R. W. Brower,et al.  Coronary Artery Atherosclerosis: Severity of the Disease, Severity of Angina Pectoris and Compromised Left Ventricular Function , 1981, Circulation.

[29]  M. Kekki.  Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemics. , 1980, Atherosclerosis.

[30]  A. van Tol,et al.  On the metabolic function of heparin-releasable liver lipase. , 1980, Biochemical and biophysical research communications.

[31]  M. Sanmarco,et al.  Angiography for study of lipid-lowering therapy. , 1979, Circulation.

[32]  P. Nestel,et al.  Severity of coronary atherosclerosis related to lipoprotein concentration. , 1978, British medical journal.

[33]  E. Nikkilä.  Metabolic regulation of plasma high density Iipoprotein concentrations , 1978 .

[34]  D. Blankenhorn,et al.  The Rate of Atherosclerosis Change during Treatment of Hyperlipoproteinemia , 1978, Circulation.

[35]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[36]  M. Lopes-Virella,et al.  Cholesterol determination in high-density lipoproteins separated by three different methods. , 1977, Clinical chemistry.

[37]  J. Murray,et al.  Variability in the Analysis of Coronary Arteriograms , 1977, Circulation.

[38]  E. Sprague,et al.  The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. , 1977, Atherosclerosis.

[39]  W. Kannel,et al.  A general cardiovascular risk profile: the Framingham Study. , 1976, The American journal of cardiology.

[40]  J. Ockene,et al.  Prevention of coronary heart disease. , 1976, British medical journal.

[41]  A Kagan,et al.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.

[42]  T. Takaro,et al.  Observer Agreement in Evaluating Coronary Angiograms , 1975, Circulation.

[43]  P. Kinnunen,et al.  An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[44]  H. Jansen,et al.  High myocardial and low hepatic lipoprotein lipase activities responsible for the initiation of atherosclerosis. , 1975, Biochemical medicine.

[45]  K. Cohn,et al.  Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man. , 1975, American heart journal.

[46]  J. Stamler.  Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[47]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[48]  S. Rössner,et al.  Serum lipoproteins and the intravenous fat tolerance test in hypothyroid patients before and during substitution therapy. , 1974, Atherosclerosis.

[49]  J. Dyerberg,et al.  Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. , 1971, Lancet.

[50]  L. Vanhaelst,et al.  Coronary-artery disease in hypothyroidism. , 1967, Lancet.

[51]  B. Murphy,et al.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. , 1967, The Journal of clinical endocrinology and metabolism.

[52]  G. Gregoratos,et al.  Myocardial infarction in young men. , 1967, The American journal of cardiology.

[53]  A. Keys,et al.  Serum cholesterol response to changes in the diet: II. The effect of cholesterol in the diet. , 1965, Metabolism: clinical and experimental.

[54]  J. Stamler,et al.  THE STATUS OF HORMONAL THERAPY FOR THE PRIMARY AND SECONDARY PREVENTION OF ATHEROSCLEROTIC CORONARY HEART DISEASE. , 1963, Progress in cardiovascular diseases.

[55]  D. Adams,et al.  Thyroid-stimulating hormone. , 1960, British medical bulletin.

[56]  B. Brodie,et al.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. , 1952, The Journal of biological chemistry.

[57]  H. Eder,et al.  Protein-lipid relationships in human plasma. I. In normal individuals. , 1951, The American journal of medicine.

[58]  A. Strøm,et al.  Mortality from circulatory diseases in Norway 1940-1945. , 1951, Lancet.

[59]  P. Allhoff,et al.  The Leiden Intervention Trial , 1991 .

[60]  M. Kornitzer,et al.  Changing trends in coronary heart disease mortality; possible explanations. , 1985, The Cardiology.

[61]  J. J. Gerbrands,et al.  Coronary Artery Dimensions from Cineangiograms-Methodology and Validation of a Computer-Assisted Analysis Procedure , 1984, IEEE Transactions on Medical Imaging.

[62]  P. Esente,et al.  Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography. , 1982, International journal of cardiology.

[63]  P. Nilsson-ehle,et al.  Lipolytic enzymes and plasma lipoprotein metabolism. , 1980, Annual review of biochemistry.

[64]  G. Assmann.  Lecithin-Cholesterol-Acyl-Transferase , 1976 .

[65]  T. Visser,et al.  Radio-immunoassay of thyroxine in unextracted serum. , 1975, The Netherlands journal of medicine.

[66]  P. Röschlau,et al.  Enzymatische Bestimmung des Gesamt-Cholesterins im Serum , 1974 .

[67]  G W Hamilton,et al.  Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. , 1974, The American journal of cardiology.

[68]  A. Wahlefeld.  Triglycerides Determination after Enzymatic Hydrolysis , 1974 .

[69]  Joseph L. Goldstein,et al.  Hyperlipidemia in Coronary Heart Disease , 1973 .

[70]  C. East,et al.  Recent advances in cardiology , 1936 .